SN

Srikanth Naidu Bandaru

Active Director Director DIN 03330358
DIN 03330358 First appointment Mar 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Srikanth Naidu Bandaru

Data last updated:

Srikanth Naidu Bandaru is a Director at Rays Speciality Hospitals Private Limited (since 2011). The company operates in Healthcare.

DIN 03330358
Primary Designation Director
Industry Healthcare
First Appointment 18 Mar 2011
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 20112011Active

Board colleagues of Srikanth Naidu Bandaru

Directorship timeline

Open interactive timeline →
Rays Speciality Hospitals Private Limited
Premium access

Shareholding and investment profile for Srikanth Naidu Bandaru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Srikanth Naidu Bandaru

Srikanth Naidu Bandaru currently holds 1 directorship: Rays Speciality Hospitals Private Limited (Director, since 18 Mar 2011).

Srikanth Naidu Bandaru was first appointed on 18 Mar 2011 as Director at Rays Speciality Hospitals Private Limited.

The current boards of Srikanth Naidu Bandaru's companies include Kanuganti Mamatha (Rays Speciality Hospitals Private Limited), Shashikanth Agarwal (Rays Speciality Hospitals Private Limited), Sunil Kumar Muddam (Rays Speciality Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available